{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:08:13Z","timestamp":1788055693983,"version":"build-2784847793"},"update-to":[{"DOI":"10.1371\/journal.pntd.0005680","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000}}],"reference-count":120,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T00:00:00Z","timestamp":1499904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007100","name":"Sandler Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12GM081266"],"award-info":[{"award-number":["K12GM081266"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI089896"],"award-info":[{"award-number":["1R01AI089896"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R21AI107390"],"award-info":[{"award-number":["1R21AI107390"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UC MEXUS-CONACYT"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005680","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T17:31:20Z","timestamp":1499967080000},"page":"e0005680","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target"],"prefix":"10.1371","volume":"11","author":[{"given":"Thavy","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Rojo-Arreola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"El-Sakkary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Jarnagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliwan","family":"Meewan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto A.","family":"Rasc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Lemieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Podust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Abagyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"McKerrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor R.","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,13]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00436-009-1546-2","article-title":"Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use","volume":"105","author":"RA Abdul-Ghani","year":"2009","journal-title":"Parasitol Res"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/cmdc.201000202","article-title":"Praziquantel and schistosomiasis","volume":"5","author":"A D\u0151mling","year":"2010","journal-title":"ChemMedChem"},{"key":"ref3","unstructured":"World Health Organization. Schistosomiasis: Fact sheet N\u00b0115: WHO; 2014. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs115\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs115\/en\/<\/ext-link>."},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4155\/fmc.15.27","article-title":"Schistosomiasis and its treatment","volume":"7","author":"CR Caffrey","year":"2015","journal-title":"Future Med Chem"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","article-title":"Schistosomiasis control: praziquantel forever?","volume":"195","author":"D Cioli","year":"2014","journal-title":"Mol Biochem Parasitol"},{"issue":"31","key":"ref6","doi-asserted-by":"crossref","first-page":"7936","DOI":"10.1002\/anie.201208390","article-title":"Schistosomiasis chemotherapy","volume":"52","author":"SA Thetiot-Laurent","year":"2013","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref7","article-title":"Accelerating work to overcome the global impact of neglected tropical diseases\u2013A roadmap for implementation","year":"2012"},{"key":"ref8","unstructured":"London Declaration Stakeholders Working Group. 2014. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/unitingtocombatntds.org\/resource\/download-report\" xlink:type=\"simple\">http:\/\/unitingtocombatntds.org\/resource\/download-report<\/ext-link>."},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbiopara.2008.11.007","article-title":"Towards an understanding of the mechanism of action of praziquantel","volume":"164","author":"AD Aragon","year":"2009","journal-title":"Mol Biochem Parasitol"},{"issue":"6164","key":"ref10","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1126\/science.1243106","article-title":"Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites","volume":"342","author":"CL Valentim","year":"2013","journal-title":"Science"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","article-title":"Susceptibility or resistance of praziquantel in human schistosomiasis: a review","volume":"111","author":"W Wang","year":"2012","journal-title":"Parasitology Research"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/med.2610030204","article-title":"Praziquantel","volume":"3","author":"P Andrews","year":"1983","journal-title":"Med Res Rev"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0014-4894(86)90184-0","article-title":"<italic>Schistosoma mansoni<\/italic>: chemotherapy of infections of different ages","volume":"61","author":"AA Sabah","year":"1986","journal-title":"Exp Parasitol"},{"issue":"9","key":"ref14","first-page":"759","article-title":"Susceptibility of <italic>Schistosoma japonicum<\/italic> to different developmental stages to praziquantel","volume":"100","author":"SH Xiao","year":"1987","journal-title":"Chin Med J (Engl)"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ijpara.2005.05.002","article-title":"Effect of praziquantel on the immature stages of <italic>Schistosoma haematobium<\/italic>","volume":"35","author":"S Botros","year":"2005","journal-title":"Int J Parasitol"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/QCO.0b013e328349156f","article-title":"Schistosomiasis: from drug deployment to drug development","volume":"24","author":"CR Caffrey","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","article-title":"Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis","volume":"21","author":"MJ Doenhoff","year":"2008","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00227-16","article-title":"Population pharmacokinetics and pharmacodynamics of praziquantel in Ugandan children with intestinal schistosomiasis: higher dosages are required for maximal efficacy","volume":"7","author":"AL Bustinduy","year":"2016","journal-title":"mBio"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF03189504","article-title":"Metabolism of praziquantel in man","volume":"3","author":"KU B\u00fchring","year":"1978","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/dkt491","article-title":"The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)","volume":"69","author":"P Olliaro","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1371\/journal.pntd.0000357","article-title":"Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment","volume":"3","author":"T Meyer","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"JA Beavo","year":"1995","journal-title":"Physiological reviews"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"DH Maurice","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/odi.12275","article-title":"Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets","volume":"21","author":"F Ahmad","year":"2015","journal-title":"Oral Diseases"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","article-title":"Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling","volume":"76","author":"M Conti","year":"2007","journal-title":"Annual Review of Biochemistry"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neurobiolaging.2014.09.029","article-title":"Accumulation of carboxy-terminal fragments of APP increases phosphodiesterase 8B","volume":"36","author":"F Kametani","year":"2015","journal-title":"Neurobiology of Aging"},{"issue":"204","key":"ref27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-642-17969-3_2","article-title":"Phosphodiesterase inhibitors: factors that influence potency, selectivity, and action","author":"SH Francis","year":"2011","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2174\/138161210790963760","article-title":"Cyclic nucleotide phosphodiesterases (PDE) and peptide motifs","volume":"16","author":"T Keravis","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"K Omori","year":"2007","journal-title":"Circulation Research"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"AT Bender","year":"2006","journal-title":"Pharmacological Reviews"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrm911","article-title":"Cyclic nucleotide research\u2014still expanding after half a century","volume":"3","author":"JA Beavo","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"24","key":"ref32","doi-asserted-by":"crossref","first-page":"14597","DOI":"10.1016\/S0021-9258(18)33316-7","article-title":"Peptide mapping of multiple forms of cyclic nucleotide phosphodiesterase","volume":"257","author":"DJ Takemoto","year":"1982","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization","volume":"370","author":"MD Houslay","year":"2003","journal-title":"Biochem J"},{"issue":"22","key":"ref34","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S1359-6446(05)03622-6","article-title":"Keynote review: phosphodiesterase-4 as a therapeutic target","volume":"10","author":"MD Houslay","year":"2005","journal-title":"Drug Discov Today"},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cellsig.2015.10.005","article-title":"Protein-protein interactions of PDE4 family members\u2014Functions, interactions and therapeutic value","volume":"28","author":"E Klussmann","year":"2016","journal-title":"Cell Signal"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.aller.2013.07.011","article-title":"Regulation of human skin mast cell histamine release by PDE inhibitors","volume":"43","author":"N Eskandari","year":"2015","journal-title":"Allergologia et Immunopathologia"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s13311-014-0309-7","article-title":"Phosphodiesterase-4 (PDE4) molecular pharmacology and Alzheimer&apos;s disease","volume":"12","author":"ME Gurney","year":"2015","journal-title":"Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3797\/scipharm.1404-08","article-title":"Selective Phosphodiesterase 4B Inhibitors: A Review","volume":"82","author":"MA Azam","year":"2014","journal-title":"Scientia Pharmaceutica"},{"issue":"9454","key":"ref39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(05)17708-3","article-title":"Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease","volume":"365","author":"BJ Lipworth","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1517\/14728222.9.6.1283","article-title":"Phosphodiesterase-4 as a potential drug target","volume":"9","author":"KY Zhang","year":"2005","journal-title":"Expert Opin Ther Targets"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1741-7015-11-96","article-title":"Phosphodiesterase 4-targeted treatments for autoimmune diseases","volume":"11","author":"N Kumar","year":"2013","journal-title":"BMC Medicine"},{"issue":"9995","key":"ref42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","year":"2015","journal-title":"Lancet"},{"issue":"1\u20133","key":"ref43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","article-title":"Phosphodiesterase inhibitors in airways disease","volume":"533","author":"K Fan Chung","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1381612820666140826114601","article-title":"Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer&apos;s disease: a translational overview","volume":"21","author":"PR Heckman","year":"2015","journal-title":"Curr Pharm Des"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00213-010-1943-3","article-title":"Inhibition of phosphodiesterase-4 reverses memory deficits produced by Abeta25-35 or Abeta1-40 peptide in rats","volume":"212","author":"YF Cheng","year":"2010","journal-title":"Psychopharmacology"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/cn3000907","article-title":"Phosphodiesterases as therapeutic targets for Alzheimer&apos;s disease","volume":"3","author":"A Garcia-Osta","year":"2012","journal-title":"ACS Chemical Neuroscience"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.12659\/MSMBR.891149","article-title":"Zaprinast and rolipram enhances spatial and emotional memory in the elevated plus maze and passive avoidance tests and diminishes exploratory activity in naive mice","volume":"20","author":"F Akar","year":"2014","journal-title":"Medical Science Monitor Basic Research"},{"issue":"20","key":"ref48","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1111\/bph.13257","article-title":"Phosphodiesterase 4D: an enzyme to remember","volume":"172","author":"R Ricciarelli","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"204","key":"ref49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-3-642-17969-3_20","article-title":"Therapeutic potential of phosphodiesterase inhibitors in parasitic diseases","author":"Y Shakur","year":"2011","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.bmcl.2012.01.119","article-title":"Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 1. Sildenafil analogs","volume":"22","author":"C Wang","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"ref51","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.bmcl.2012.01.118","article-title":"Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 2. Tadalafil analogs","volume":"22","author":"SO Ochiana","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"5733","key":"ref52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1126\/science.1112642","article-title":"The genome of the African trypanosome <italic>Trypanosoma brucei<\/italic>","volume":"309","author":"M Berriman","year":"2005","journal-title":"Science"},{"issue":"23","key":"ref53","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1021\/jm201148s","article-title":"Pharmacological validation of <italic>Trypanosoma brucei<\/italic> phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness","volume":"54","author":"ND Bland","year":"2011","journal-title":"J Med Chem"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1096\/fj.06-6818com","article-title":"The <italic>Trypanosoma brucei<\/italic> cAMP phosphodiesterases TbrPDEB1 and TbrPDEB2: flagellar enzymes that are essential for parasite virulence","volume":"21","author":"M Oberholzer","year":"2007","journal-title":"FASEB J"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/cbdd.12443","article-title":"Repurposing human PDE4 inhibitors for neglected tropical diseases. Evaluation of analogs of the human PDE4 inhibitor GSK-256066 as inhibitors of PDEB1 of <italic>Trypanosoma brucei<\/italic>","volume":"85","author":"SO Ochiana","year":"2015","journal-title":"Chem Biol Drug Des"},{"issue":"7","key":"ref56","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1073\/pnas.002031599","article-title":"Cloning and characterization of a cAMP-specific phosphodiesterase (TbPDE2B) from <italic>Trypanosoma brucei<\/italic>","volume":"99","author":"A Rascon","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/infdis\/jir857","article-title":"Pharmacological validation of <italic>Trypanosoma brucei<\/italic> phosphodiesterases as novel drug targets","volume":"206","author":"HP de Koning","year":"2012","journal-title":"J Infect Dis"},{"issue":"7","key":"ref58","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bmc.2016.02.032","article-title":"Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals","volume":"24","author":"J Veerman","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"20","key":"ref59","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1021\/jm301059b","article-title":"Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1","volume":"55","author":"KM Orrling","year":"2012","journal-title":"J Med Chem"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2180-6-25","article-title":"Cyclic nucleotide specific phosphodiesterases of <italic>Leishmania major<\/italic>","volume":"6","author":"A Johner","year":"2006","journal-title":"BMC Microbiology"},{"issue":"10","key":"ref61","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4155\/fmc.11.77","article-title":"Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite","volume":"3","author":"T Seebeck","year":"2011","journal-title":"Future Med Chem"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molbiopara.2005.09.005","article-title":"TcPDE4, a novel membrane-associated cAMP-specific phosphodiesterase from <italic>Trypanosoma cruzi<\/italic>","volume":"145","author":"GD Alonso","year":"2006","journal-title":"Mol Biochem Parasitol"},{"issue":"Pt 1","key":"ref63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/BJ20050425","article-title":"PfPDE1, a novel cGMP-specific phosphodiesterase from the human malaria parasite <italic>Plasmodium falciparum<\/italic>","volume":"392","author":"K Yuasa","year":"2005","journal-title":"Biochem J"},{"issue":"4","key":"ref64","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/cb501004q","article-title":"Identification of potent phosphodiesterase inhibitors that demonstrate cyclic nucleotide-dependent functions in apicomplexan parasites","volume":"10","author":"BL Howard","year":"2015","journal-title":"ACS Chem Biol"},{"issue":"1","key":"ref65","doi-asserted-by":"crossref","first-page":"e1455","DOI":"10.1371\/journal.pntd.0001455","article-title":"A systematically improved high quality genome and transcriptome of the human blood fluke <italic>Schistosoma mansoni<\/italic>","volume":"6","author":"AV Protasio","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"7253","key":"ref66","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature08160","article-title":"The genome of the blood fluke <italic>Schistosoma mansoni<\/italic>","volume":"460","author":"M Berriman","year":"2009","journal-title":"Nature"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1645\/GE-52R1","article-title":"The involvement of cyclic adenosine monophosphate in the control of schistosome miracidium cilia","volume":"90","author":"H Matsuyama","year":"2004","journal-title":"J Parasitol"},{"issue":"5","key":"ref68","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF00931132","article-title":"Possible roles of cAMP and Ca2+ in the regulation of miracidial transformation in <italic>Schistosoma mansoni<\/italic>","volume":"75","author":"F Kawamoto","year":"1989","journal-title":"Parasitol Res"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.exppara.2009.12.021","article-title":"The identification of inhibitors of <italic>Schistosoma mansoni<\/italic> miracidial transformation by incorporating a medium-throughput small-molecule screen","volume":"125","author":"AS Taft","year":"2010","journal-title":"Exp Parasitol"},{"issue":"5832","key":"ref70","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.1142189","article-title":"An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site","volume":"316","author":"FL Rock","year":"2007","journal-title":"Science"},{"issue":"2","key":"ref71","first-page":"13","article-title":"From the test tube to the treatment room: fundamentals of boron-containing compounds and their relevance to dermatology","volume":"7","author":"JQ Del Rosso","year":"2014","journal-title":"The Journal of Clinical and Aesthetic Dermatology"},{"issue":"3","key":"ref72","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1128\/AAC.02058-12","article-title":"Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria","volume":"57","author":"V Hernandez","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"19","key":"ref73","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1016\/j.febslet.2012.07.058","article-title":"Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center","volume":"586","author":"YR Freund","year":"2012","journal-title":"FEBS Lett"},{"issue":"4","key":"ref74","first-page":"390","article-title":"Crisaborole Topical Ointment, 2%: A nonsteroidal, topical, anti-inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis","volume":"15","author":"K Jarnagin","year":"2016","journal-title":"Journal of Drugs in Dermatology: JDD"},{"issue":"3","key":"ref75","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","article-title":"Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults","volume":"75","author":"AS Paller","year":"2016","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"ref76","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4155\/fmc.11.80","article-title":"Benzoxaboroles: a new class of potential drugs for human African trypanosomiasis","volume":"3","author":"RT Jacobs","year":"2011","journal-title":"Future Med Chem"},{"key":"ref77","unstructured":"Drugs for Neglected Diseases initiative. SCYX-7158 Oxaborole: Drugs for Neglected Diseases initiative; 2017. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.dndi.org\/diseases-projects\/portfolio\/scyx-7158\/\" xlink:type=\"simple\">https:\/\/www.dndi.org\/diseases-projects\/portfolio\/scyx-7158\/<\/ext-link>."},{"issue":"7","key":"ref78","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pt.2015.03.009","article-title":"Knocking down schistosomes\u2014promise for lentiviral transduction in parasites","volume":"31","author":"J Hagen","year":"2015","journal-title":"Trends Parasitol"},{"issue":"12","key":"ref79","doi-asserted-by":"crossref","first-page":"E1414","DOI":"10.1073\/pnas.1419906112","article-title":"Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4","volume":"112","author":"P Cedervall","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1054-3589(08)60128-3","article-title":"The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions","volume":"44","author":"MD Houslay","year":"1998","journal-title":"Advances in Pharmacology"},{"issue":"2","key":"ref81","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2009.09.007","article-title":"Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown","volume":"35","author":"MD Houslay","year":"2010","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"ref82","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/BJ20131681","article-title":"The upstream conserved regions (UCRs) mediate homo- and hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s)","volume":"459","author":"M Xie","year":"2014","journal-title":"Biochem J"},{"issue":"43","key":"ref83","doi-asserted-by":"crossref","first-page":"40212","DOI":"10.1074\/jbc.M203585200","article-title":"Dimerization of the type 4 cAMP-specific phosphodiesterases is mediated by the upstream conserved regions (UCRs)","volume":"277","author":"W Richter","year":"2002","journal-title":"J Biol Chem"},{"key":"ref84","first-page":"3","article-title":"Cyclic nucleotide phosphodiesterases in health and disease","author":"J.A Beavo","year":"2006"},{"issue":"5472","key":"ref85","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1126\/science.288.5472.1822","article-title":"Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity","volume":"288","author":"RX Xu","year":"2000","journal-title":"Science"},{"issue":"28","key":"ref86","doi-asserted-by":"crossref","first-page":"16526","DOI":"10.1074\/jbc.271.28.16526","article-title":"Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation","volume":"271","author":"C Sette","year":"1996","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"ref87","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/bj3330139","article-title":"cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model","volume":"333","author":"R Hoffmann","year":"1998","journal-title":"Biochem J"},{"issue":"3","key":"ref88","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.bjp.0704743","article-title":"Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1)","volume":"136","author":"SJ MacKenzie","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"4","key":"ref89","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bjp.0703636","article-title":"Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases","volume":"131","author":"GS Baillie","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"11","key":"ref90","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.cellsig.2006.07.018","article-title":"Oxidative stress employs phosphatidyl inositol 3-kinase and ERK signalling pathways to activate cAMP phosphodiesterase-4D3 (PDE4D3) through multi-site phosphorylation at Ser239 and Ser579","volume":"18","author":"EV Hill","year":"2006","journal-title":"Cell Signal"},{"issue":"22","key":"ref91","doi-asserted-by":"crossref","first-page":"16609","DOI":"10.1074\/jbc.275.22.16609","article-title":"ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions","volume":"275","author":"SJ MacKenzie","year":"2000","journal-title":"J Biol Chem"},{"issue":"4","key":"ref92","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/ml100013s","article-title":"Discovery of novel benzoxaborole-based potent antitrypanosomal agents","volume":"1","author":"D Ding","year":"2010","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"12","key":"ref93","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0968-0004(98)01293-6","article-title":"The HD domain defines a new superfamily of metal-dependent phosphohydrolases","volume":"23","author":"L Aravind","year":"1998","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"ref94","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng.1065","article-title":"Whole-genome sequence of <italic>Schistosoma haematobium<\/italic>","volume":"44","author":"ND Young","year":"2012","journal-title":"Nat Genet"},{"issue":"7253","key":"ref95","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature08140","article-title":"The <italic>Schistosoma japonicum<\/italic> genome reveals features of host-parasite interplay","volume":"460","author":"F Liu","year":"2009","journal-title":"Nature"},{"issue":"6","key":"ref96","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0898-6568(97)00169-1","article-title":"Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors","volume":"10","author":"N Saldou","year":"1998","journal-title":"Cell Signal"},{"issue":"49","key":"ref97","doi-asserted-by":"crossref","first-page":"31334","DOI":"10.1074\/jbc.271.49.31334","article-title":"The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram","volume":"271","author":"E Huston","year":"1996","journal-title":"J Biol Chem"},{"issue":"10","key":"ref98","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1128\/MCB.13.10.6558","article-title":"A family of human phosphodiesterases homologous to the dunce learning and memory gene product of D<italic>rosophila melanogaster<\/italic> are potential targets for antidepressant drugs","volume":"13","author":"G Bolger","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"7","key":"ref99","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1371\/journal.pntd.0000478","article-title":"Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening","volume":"3","author":"MH Abdulla","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"ref100","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.3390\/molecules200610873","article-title":"Anti-schistosomal activity of cinnamic acid esters: eugenyl and thymyl cinnamate induce cytoplasmic vacuoles and death in schistosomula of <italic>Schistosoma mansoni<\/italic>","volume":"20","author":"J Glaser","year":"2015","journal-title":"Molecules"},{"issue":"1","key":"ref101","doi-asserted-by":"crossref","first-page":"e0004356","DOI":"10.1371\/journal.pntd.0004356","article-title":"Structure-bioactivity relationship for benzimidazole thiophene inhibitors of polo-like kinase 1 (PLK1), a potential drug target in <italic>Schistosoma mansoni<\/italic>","volume":"10","author":"T Long","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref102","doi-asserted-by":"crossref","first-page":"e1494","DOI":"10.1371\/journal.pntd.0001494","article-title":"WormAssay: a novel computer application for whole-plate motion-based screening of macroscopic parasites","volume":"6","author":"C Marcellino","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref103","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1534\/genetics.105.054007","article-title":"The Dunce cAMP phosphodiesterase PDE-4 negatively regulates G alpha(s)-dependent and G alpha(s)-independent cAMP pools in the <italic>Caenorhabditis elegans<\/italic> synaptic signaling network","volume":"173","author":"NK Charlie","year":"2006","journal-title":"Genetics"},{"issue":"29","key":"ref104","doi-asserted-by":"crossref","first-page":"30338","DOI":"10.1074\/jbc.M312687200","article-title":"The oligomerization state determines regulatory properties and inhibitor sensitivity of type 4 cAMP-specific phosphodiesterases","volume":"279","author":"W Richter","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"ref105","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cellsig.2014.12.009","article-title":"Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains","volume":"27","author":"GB Bolger","year":"2015","journal-title":"Cell Signal"},{"issue":"Pt 1","key":"ref106","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/bj3260053","article-title":"Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells","volume":"326","author":"RJ Owens","year":"1997","journal-title":"Biochem J"},{"issue":"204","key":"ref107","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-642-17969-3_7","article-title":"Small molecule allosteric modulators of phosphodiesterase 4","author":"ME Gurney","year":"2011","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"10","key":"ref108","doi-asserted-by":"crossref","first-page":"e850","DOI":"10.1371\/journal.pntd.0000850","article-title":"RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening","volume":"4","author":"S \u0160tefani\u0107","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"ref109","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijpddr.2014.07.005","article-title":"Serum albumin and alpha-1 acid glycoprotein impede the killing of <italic>Schistosoma mansoni<\/italic> by the tyrosine kinase inhibitor Imatinib","volume":"4","author":"S Beckmann","year":"2014","journal-title":"International Journal for Parasitology Drugs and Drug Resistance"},{"issue":"1","key":"ref110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0014-4894(74)90005-8","article-title":"<italic>Schistosoma mansoni<\/italic>: simplified method for the production of schistosomules","volume":"35","author":"DG Colley","year":"1974","journal-title":"Exp Parasitol"},{"issue":"2","key":"ref111","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2307\/3280632","article-title":"Cultivation of <italic>Schistosoma mansoni in vitro<\/italic>. I. Establishment of cultures from cercariae and development until pairing","volume":"67","author":"PF Basch","year":"1981","journal-title":"J Parasitol"},{"issue":"3","key":"ref112","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1006\/jmbi.1994.1052","article-title":"Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins","volume":"235","author":"R Abagyan","year":"1994","journal-title":"J Mol Biol"},{"issue":"12","key":"ref113","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"GL Card","year":"2004","journal-title":"Structure"},{"issue":"2","key":"ref114","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/prot.20185","article-title":"Large-scale prediction of protein geometry and stability changes for arbitrary single point mutations","volume":"57","author":"AJ Bordner","year":"2004","journal-title":"Proteins"},{"issue":"1","key":"ref115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/genetics\/77.1.71","article-title":"The genetics of <italic>Caenorhabditis elegans<\/italic>","volume":"77","author":"S Brenner","year":"1974","journal-title":"Genetics"},{"issue":"6","key":"ref116","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cmet.2008.04.012","article-title":"Serotonin regulates C. elegans fat and feeding through independent molecular mechanisms","volume":"7","author":"S Srinivasan","year":"2008","journal-title":"Cell Metabolism"},{"issue":"3","key":"ref117","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/genetics\/141.3.977","article-title":"Identification and cloning of unc-119, a gene expressed in the <italic>Caenorhabditis elegans<\/italic> nervous system","volume":"141","author":"M Maduro","year":"1995","journal-title":"Genetics"},{"issue":"1\u20132","key":"ref118","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cell.2014.12.028","article-title":"Kynurenic acid is a nutritional cue that enables behavioral plasticity","volume":"160","author":"GA Lemieux","year":"2015","journal-title":"Cell"},{"issue":"6","key":"ref119","doi-asserted-by":"crossref","first-page":"e1004394","DOI":"10.1371\/journal.pgen.1004394","article-title":"Loss of a neural AMP-activated kinase mimics the effects of elevated serotonin on fat, movement, and hormonal secretions","volume":"10","author":"KA Cunningham","year":"2014","journal-title":"PLoS Genetics"},{"issue":"10","key":"ref120","doi-asserted-by":"crossref","first-page":"e1000213","DOI":"10.1371\/journal.pgen.1000213","article-title":"A TRPV channel modulates <italic>C<\/italic>. <italic>elegans<\/italic> neurosecretion, larval starvation survival, and adult lifespan","volume":"4","author":"BH Lee","year":"2008","journal-title":"PLoS Genetics"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0005680","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005680","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T23:00:54Z","timestamp":1659222054000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005680"}},"subtitle":[],"editor":[{"given":"Timothy G.","family":"Geary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,13]]},"references-count":120,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005680","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0005680","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,13]]}}}